Related Experiment Videos
Traumatic optic neuropathy: visual outcome following combined therapy protocol.
M G Rajiniganth1, Ashok K Gupta, Amod Gupta
1Department of Otorhinolaryngology and Head and Neck Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Archives of Otolaryngology--Head & Neck Surgery
|November 19, 2003
Summary
Early combined therapy for traumatic optic neuropathy, including methylprednisolone and endoscopic optic nerve decompression, significantly improves visual outcomes. Prompt treatment within 7 days of injury is crucial for better results in optic nerve injury patients.
Area of Science:
- Ophthalmology
- Neurosurgery
- Trauma Surgery
Background:
- Traumatic optic neuropathy (TON) can lead to severe visual impairment.
- Effective treatment strategies for TON are critical for visual recovery.
Purpose of the Study:
- To evaluate the visual outcomes of a combined therapy protocol for traumatic optic neuropathy.
- To assess the efficacy of methylprednisolone injections and endoscopic optic nerve decompression.
Main Methods:
- Prospective, nonrandomized study involving 44 patients with indirect optic nerve injury.
- Treatment involved a combined protocol of methylprednisolone injections and endoscopic optic nerve decompression.
- Visual acuity was the primary outcome measure.
Main Results:
- A 70% visual improvement rate was observed when treatment commenced within 7 days of injury.
- Only 24% of patients improved when treatment was initiated after 7 days.
- Factors influencing prognosis included time to treatment, visual loss severity, and fracture patterns on CT scans.
Conclusions:
- Combined therapy of methylprednisolone and endoscopic optic nerve decompression offers a favorable risk-benefit profile for TON.
- Endoscopic optic nerve decompression is a minimally invasive procedure with no adverse cosmetic effects.
- Timely intervention is a significant factor in achieving better visual outcomes in traumatic optic neuropathy.